Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over three decades.

Autor: Papini C; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Mirzaei S S; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Xing M; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Tonning Olsson I; Department of Pediatrics, Skåne University Hospital, Lund, Sweden.; Department of Clinical Sciences, Pediatrics, Lund University, Lund, Sweden., Salloum R; Pediatric Brain Tumor Program, Division of Hematology, Oncology & Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA., de Blank PMK; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, The Cure Starts Now Brain Tumor Center, Cincinnati, OH, USA., Lange KR; Division of Pediatric Oncology, Hackensack Meridian Children's Health, Hackensack, NJ, USA., King TZ; Department of Psychology, Georgia State University, Atlanta, USA.; Neuroscience Institute, Georgia State University, Atlanta, USA., Srivastava D; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Leisenring WM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Howell RM; Division of Radiation Oncology, Department of Radiation Physics, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA., Oeffinger KC; Department of Medicine, Duke University, Durham, NC, USA., Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA., Armstrong GT; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA., Krull KR; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Brinkman TM; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Jul 04. Date of Electronic Publication: 2024 Jul 04.

Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma.

Autor: Papini C; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Mirzaei S S; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Xing M; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Tonning Olsson I; Department of Pediatrics, Skåne University Hospital, Lund, Sweden.; Department of Clinical Sciences, Pediatrics, Lund University, Lund, Sweden., de Blank PMK; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, The Cure Starts Now Brain Tumor Center, Cincinnati, OH, USA., Lange KR; Divison of Pediatric Oncology, Hackensack Meridian Children's Health, Hackensack, NJ, USA., Salloum R; Pediatric Brain Tumor Program, Division of Hematology, Oncology & Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, USA., Srivastava D; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Leisenring WM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Howell RM; Division of Radiation Oncology, Department of Radiation Physics, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA., Oeffinger KC; Department of Medicine, Duke University, Durham, NC, USA., Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA., Armstrong GT; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA., Krull KR; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Brinkman TM; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Feb 08; Vol. 116 (2), pp. 288-298.

MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.

Autor: de Blank PMK; Department of Pediatrics, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Gross AM; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Akshintala S; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Blakeley JO; Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA., Bollag G; Plexxikon Inc., Berkeley, California, USA., Cannon A; Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama, USA., Dombi E; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Fangusaro J; Children's Hospital of Atlanta, Emory University and the Aflac Cancer Center, Atlanta, Georgia, USA., Gelb BD; Department of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Hargrave D; Department of Oncology, Great Ormond Street Hospital for Children, London, UK., Kim A; Center for Neuroscience and Behavioral Medicine and Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA., Klesse LJ; Department of Pediatrics, Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, Texas, USA., Loh M; Benioff Children's Hospital, University of California San Francisco, San Francisco, California, USA., Martin S; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Moertel C; Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA., Packer R; Center for Neuroscience and Behavioral Medicine and Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA., Payne JM; Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria, Australia., Rauen KA; Department of Pediatrics, University of California Davis, Sacramento, California, USA., Rios JJ; Center for Pediatric Bone Biology and Translational Research, Scottish Rite for Children, Dallas, Texas, USA., Robison N; Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California, USA., Schorry EK; Department of Pediatrics, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Shannon K; Benioff Children's Hospital, University of California San Francisco, San Francisco, California, USA., Stevenson DA; Department of Pediatrics, Division of Medical Genetics, Stanford University, Stanford, California, USA., Stieglitz E; Benioff Children's Hospital, University of California San Francisco, San Francisco, California, USA., Ullrich NJ; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA., Walsh KS; Center for Neuroscience and Behavioral Medicine and Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA., Weiss BD; Department of Pediatrics, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Wolters PL; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Yohay K; Department of Neurology and Pediatrics, New York University Grossman School of Medicine, New York, New York, USA., Yohe ME; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Widemann BC; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Fisher MJ; Division of Oncology, The Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2022 Nov 02; Vol. 24 (11), pp. 1845-1856.